drugset / Trial / NCT07281495
Taldefgrobep Alfa in Adults With Overweight and Obesity
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a multicenter, randomized, double-blind, placebo-controlled, multiple dose study to evaluate the efficacy, safety, and tolerability of taldefgrobep alfa in adults with overweight and obesity, with an open-label extension.
Timeline
- Start
- 2025-11-24
- Primary completion
- 2026-09
- Completion
- 2026-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Taldefgrobep Alfa | Protein / enzyme biologic | — | Subcutaneous |